NCT06682910 · ClinicalTrials.gov record · last posted 2026-08-21
Assessment of Safety and Accuracy of the Microtech System in Patients Undergoing Left Ventricular Assist Device Implantation
Study acronym: Microtech-LVAD
StatusActive, Not Recruiting
PhaseNot applicable
Started2024-12-15
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The Microtech-LVAD study is designed as a prospective, single arm, multi-center early feasibility study. Approximately 15 patients will be enrolled in the study. The study will be limited to patients in whom it is decided, based on routine clinical practice, that the LVAD will be implanted via a midline sternotomy. In the first 5 study patients, the device will be implanted in the RA; subsequently, the device will be implanted in the LA unless the patient is deemed at high risk of post-LVAD right heart failure, in which case the device will be placed in the RA
Protocol amendment history
3 changes detected by DataLookout
2026-08-22
notable
Enrollment closed, study ongoing
2026-08-22
notable
Primary completion pushed: 2026-05 → 2026-11
2026-08-22
minor
Completion pushed: 2026-11 → 2027-12
| NCT Number |
NCT06682910 |
| Lead Sponsor |
Microtech Medical Technologies, Ltd
|
| Conditions |
Heart Failure |
| Enrollment |
15 participants |
| Start Date |
2024-12-15 |
| Primary Completion |
2026-11 (estimated) |
| Study Completion |
2027-12 (estimated) |
| Updated on ClinicalTrials.gov |
2026-08-21 |